CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving breast cancer treatment by identifying genetic alterations in tumors and their relationship to drug responses. It aims to develop non-invasive monitoring tools to guide personalized therapies, leveraging extensive molecular data from thousands of cases.
Breast cancer is the most common cancer among European women showing high clinical and molecular heterogeneity.
Current clinical management causes patients overtreatment with implications on both patients’ quality of life and healthcare costs.
Moreover, intrinsic or acquired tumor resistance to treatment leads to incurable metastatic progression in a significant proportion of patients.
Advances in cancer genomics highlighted a high inter- and intra-tumor genetic heterogeneity, reinforcing the ne…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.